Carol Giltner Gallagher - 31 Mar 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact
Issuer symbol
ATRA
Transactions as of
31 Mar 2024
Net transactions value
$0
Form type
4
Filing time
02 Apr 2024, 18:12:10 UTC
Previous filing
23 Jan 2024
Next filing
10 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +150,000 +31% $0.000000 629,608 31 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units shall vest on the date of the Issuer's annual meeting of stockholders for the calendar year 2025, subject to the Reporting Person's continuous service.
F2 This amount includes an additional 20,190 shares that were previously inadvertently omitted from the Reporting Person's aggregate beneficial ownership.